New Hypertension Treatment Tool Improves Clinician Adherence

Archyde New Study Uncovers Why Doctors Aren’t Always following High Blood Pressure Guidelines By Archyde News Service | July 1,2024 A novel classification system sheds light on why clinicians sometimes stray from hypertension treatment guidelines,offering potential solutions to improve patient care and reduce the risk of heart attack and stroke. Photo Credit: iStock.com/Bucsa Nicolae Despite … Read more

New ASCO Guidelines for Fertility Preservation in Cancer

The American Society of Clinical Oncology (ASCO) has released updated guidelines to guide fertility preservation for people with cancer, with the previous update published in 2018. The 2025 update reflects substantial growth in the evidence base, with 166 studies incorporated compared with just 61 studies in the 2018 guidelines. According to the authors, this expanded … Read more

New Rosacea Treatment Algorithms: What’s Changed?

Are you tired of the one-size-fits-all approach to skincare? Recent advancements in the treatment of rosacea are revolutionizing how this condition is managed, emphasizing a personalized approach based on individual symptoms. Learn how new treatment algorithms are helping physicians provide more targeted and effective care for rosacea sufferers,offering hope for improved outcomes and quality of … Read more

Updated Rosacea Treatment Algorithms Available

Reflecting the growing understanding of rosacea as a continuum of systemic inflammation, new National Rosacea Society (NRS) Treatment Algorithms suggest therapies based not on the rosacea subtype but on the individual patients’ clinical signs and symptoms. The algorithms were published on the NRS website’s physician section on March 25. New Diagnostic Approach The algorithms change … Read more

New Canadian Guideline for Postpartum Physical Activity

During the first year after giving birth, mothers should work up to 120 min/wk of moderate to vigorous physical activity, such as brisk walking and muscle-strengthening exercises, according to a new Canadian guideline. The document focuses on postpartum physical activity, sedentary behavior, and sleep. Produced by the Canadian Society for Exercise Physiology, the guideline also … Read more

Stop Smoking Drugs Don’t Promote Congenital Malformations

The use of smoking cessation medications during the first trimester of pregnancy posed no greater risk for major congenital malformations (MCMs) in infants than smoking, based on a meta-analysis of approximately 400,000 infants.  “Maternal smoking during pregnancy is the leading cause of harms to both mother and baby, contributing to outcomes such as preterm birth, … Read more

Noninvasive Stents as Good as Surgery for Triple-Vessel Disease

CHICAGO — Patients with severe triple-vessel heart disease who underwent a less-invasive stent procedure fared just as well as those who underwent open-heart bypass surgery after 5 years, the FAME 3 trial shows. The results are in marked contrast to earlier studies, which showed that patients with triple-vessel disease were less likely to die or … Read more

Low-Dose Apixaban Best for Long-Term Use in Cancer

CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as the high dose in preventing recurrent venous thromboembolism (VTE) in patients with active cancer who completed at least 6 months of anticoagulant treatment after a clot, and results in a lower rate of clinically relevant bleeding, the API-CAT trial shows. “Our results indicate … Read more

BP Below 130 mm Hg Linked to CV Benefit in Octogenarians

TOPLINE: Among adults aged 80 years or older on antihypertensive medications, intensive systolic blood pressure (SBP) control (below 130 mm Hg) was associated with a significantly lower risk for cardiovascular mortality than SBP of 130-160 mm Hg. METHODOLOGY: Current guidelines advocate for more intensive BP control but remain inconsistent and lack strong evidence for adults … Read more

Adjuvant Chemo vs Radiotherapy Alone in Cervical Cancer

New findings on radiation plus adjuvant chemotherapy in patients with intermediate-risk cervical cancer seem to spell the end for the dual therapy in this group.  Results from a phase 3 clinical trial of 316 women who’d had radical hysterectomies found that adjuvant chemotherapy as treatment for their early-stage, intermediate-risk cervical carcinoma did not improve outcomes … Read more